Actively Recruiting
Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
Led by Université du Québec à Trois-Rivières · Updated on 2024-12-17
70
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors). A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.
CONDITIONS
Official Title
Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction
- Willing and able to provide written informed consent
- Understand and read the French language
- Have an internet connection and a working email address
You will not qualify if you...
- Anosmia and hyposmia before COVID-19 infection
- Known chronic rhinosinusitis with or without nasal polyposis
- Received radiotherapy or chemotherapy for head and neck tumors
- Diagnosis of Alzheimer's, Parkinson's, multiple sclerosis, or other neurodegenerative diseases
- Presence of brain tumor or ENT diagnosis
- History of naso-sinus surgery
- History of traumatic brain injury
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada, G8Z 4M3
Actively Recruiting
Research Team
J
Johannes A Frasnelli, PhD
CONTACT
F
Frank Cloutier, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here